Analysis of treatment response about low-dose (0.01%) atropine eye-drops in myopic children

Myopia usually commences during primary school and progresses until the mean age of 16 years. Topical low-dose (0.01%) atropine eye-drop appears to be safe and efficacious for myopia control in children. However, in some cases, a higher concentration of atropine is required in some cases because low-dose atropine treatment is not effective.This is a retrospective study among young myopic children between 5 and 15 years with myopia progression >...